¤é´Á |
¥¼¤W¥«ÂdªÑ²¼¤½¥q¦WºÙ |
·s»D¼ÐÃD |
2019/3/2 | ¼üºÓ¥Í§ÞÂåÃÄ ¿³ | ¦³Ãö¦L«×»sÃĤ½¥qHetero Labs Ltd.©Ò¥Í²£¤§ì®ÆÃÄLosartan§t¦³¡u |
¦³Ãö¦L«×»sÃĤ½¥qHetero Labs Ltd.©Ò¥Í²£¤§ì®ÆÃÄLosartan§t¦³¡uN-¨Èµv°ò-N-¥Ò°ò-4-®ò°ò¤B»Ä¡AN-nitros-N-methyl-4-aminobutyric acid¡v(NMBA)¦¨¤À»¡©ú
1.¨Æ¹êµo¥Í¤é:108/03/02 2.¤½¥q¦WºÙ:¼üºÓ¥Í§ÞÂåÃĪѥ÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò(Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¤@.TFDA¤µ¤é(3/2)¦¬¨ì¬ü°ê(FDA)¦³Ãö¦L«×»sÃĤ½¥qHetero Labs Ltds ©Ò¥Í²£¤§ì®ÆÃÄLosartanÅç¥X¡uN-¨Èµv°ò-N-¥Ò°ò-4-®ò°ò ¤B»Ä¡AN-nitros-N-methyl-4-aminobutyric acid¡v(NMBA)¤§¤£¯Â ª«¡A¸Óµ¥¦¨¤ÀÁö¨ã°Êª«PÀù©Ê¡AµM¹ï¤HÃþ¸ê®Æ©|¥¼ÃÒ©ú¡C ¤G.TFDA°ò©ó·ÀI¦Ò¶q¡A°w¹ï¨Ï¥ÎHetero Labs Ltd.©Ò²£»s¤§ì®Æ ÃÄLosartan¶i¦æ»s¾¯¥Í²£¤§²£«~¡An¨D¥ý¦æ¹w¨¾©Ê¤U¬[§@·~¡A¨Ã ¦P¨B¿ì²z©â¼ËÀËÅç¡A«ÝÀË´ú«á¡AY²Å¦X³W©w¡A±o¦A¦æ¤W¬[¡FY¤£ ²Å¦X³W©w¡A±N¥ß§Y¿ì²z¦^¦¬§@·~¡C 6.¦]À³±¹¬I: ¤@.¥»¤½¥q°ò©ó¥Á²³¥ÎÃĦw¥þ¡AÀ£¹ç®®½¤¦ç¿õ50/12.5²@§J±N°t¦X TFDA¤§n¨D¡A¥ý¦æ±Ò°Ê¹w¨¾©Ê¤U¬[§@·~¡A¨Ã½ÐÂåÀø°|©Ò¼È°±³B¤è¡C ¤G.¥Ø«e¦U°êÃĨå¬Ò¥¼q©wNMBA¤§ÀËÅç¤èªk¤Î¶q¼Ð·Ç¡A¥»¤½¥q °£¥ß§Y°t¦X©â¼Ë¥~¡A¤´´ÁTFDAºÉ§Ö½T»{ÀËÅç¤èªk¤Î¶q¼Ð·Ç¡A ¥H½T«O°ê¤H¥ÎÃĦw¥þ¡C ¤T.Y¥»¤½¥q²£«~ÀËÅç«á«Y²Å¦XTFDA©Òq¤§¼Ð·Ç¡A¦A¦æ¤W¬[¡FY ¤£²Å¦X³W©w¡A¥ç±N¥ß§Y¿ì²z¦^¦¬§@·~¡C ¥|.¸Ó²£«~¥ç¦³¦VTFDAµn°O²Ä¤G¨Ó·½¡A¥»¤½¥q¥i¥ß§Y§ë²£¡AÁקK ¼vÅT¥Á²³n¥Î»Ý¨D¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¨ÌTFDA¤§»¡©ú¡A¥Ø«e¶È¥ý°w¹ï²£«~¶i¦æ¤U¬[ §@·~¡AYÀËÅç«á«Y²Å¦X³W½d¡A±N¥i¦A¦æ¤W¬[¡FYÀËÅ礣²Å¦X³W ©w¦Ó¶·¶i¦æ¦^¦¬§@·~®É¡A¥»¤½¥q¥ç±N¦Vì®Æ¨ÑÀ³°Ó¶i¦æ¨DÀv§@ ·~¡A¬G¥»¨Æ¥ó¹ï¥»¤½¥q°]°È·~°È©|µL«¤j¼vÅT¡C
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/3/2 | «n«T°ê»Ú | ¤½§i¥»¤½¥q·~°È¥DºÞ²§°Ê |
1.¤HûÅܰʧO¡]½Ð¿é¤Jµo¨¥¤H¡B¥N²zµo¨¥¤H¡B«nÀç¹B¥DºÞ¡B°]°È¥DºÞ¡B ·|p¥DºÞ¡B¬ãµo¥DºÞ©Î¤º³¡½]®Ö¥DºÞ¡^:°ÆÁ`¸g²z 2.µo¥ÍÅܰʤé´Á:108/02/28 3.ÂÂ¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:¬Iºa©¾ °ÆÁ`¸g²z 4.·s¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:§d¤¯¤s Á`¸g²z¼È¥N 5.²§°Ê±¡§Î¡]½Ð¿é¤J¡uÃ㾡v¡B¡u¾°È½Õ¾ã¡v¡B¡u¸ê»º¡v¡B¡u°h¥ð¡v¡B¡u¦º¤`¡v©Î¡u·s ¥ô¡v¡^:Ãã¾ 6.²§°Êì¦]:Ó¤H¥Í²P³W¹º 7.¥Í®Ä¤é´Á:108/02/28 8.·s¥ôªÌÁpµ¸¹q¸Ü:02-26777429 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥ÑÁ`¸g²z§d¤¯¤s¥ý¥Í¼È¥N¡A «Ý¸³¨Æ·|©e¥ô·s¥ô·~°È¥DºÞ¡C
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/3/2 | ´º³Í¥Íª«¬ì§Þ ¿³ | ´º³Í»PùÚÁl¥Íª«ÂåÃĬì§Þ(¤W®ü)¦³¤½¥qñqJKB-122¤ÎJKB-133±ÂÅv |
´º³Í»PùÚÁl¥Íª«ÂåÃĬì§Þ(¤W®ü)¦³¤½¥qñqJKB-122¤ÎJKB-133±ÂÅv¦X¬ù
1.¨Æ¹êµo¥Í¤é:108/03/02 2.«´¬ù©Î©Ó¿Õ¬Û¹ï¤H:ùÚÁl¥Íª«ÂåÃĬì§Þ(¤W®ü)¦³¤½¥q 3.»P¤½¥qÃö«Y:µL 4.«´¬ù©Î©Ó¿Õ°_¨´¤é´Á(©Î¸Ñ°£¤é´Á):108/03/02 5.¥Dn¤º®e(¸Ñ°£ªÌ¤£¾A¥Î):¥»¤½¥q»PùÚÁl¥Íª«ÂåÃĬì§Þ(¤W®ü)¦³¤½¥q (NEWSOARA BIOPHARMA CO., LTD)(¥H¤U²ºÙùÚÁl¥Íª«ÂåÃÄ)ñ¸pJKB-122·sÃÄ¿W®a±ÂÅv ¨È¬w¥«³õ¶}µo»P°Ó·~¤Æ¤ÎJKB-133·sÃĤ§Á{§É«e¦@¦P¶}µo¦X¬ù¡C 6.¨î±ø´Ú(¸Ñ°£ªÌ¤£¾A¥Î):¨ÌÂù¤èñq¤§«O±K¦X¬ù¡AÂù¤è¹ï©ó¨ãÅ騽µ{¸O´Ú¤ÎÅv§Qª÷¬Ò ¨ã¦³«O±K¸q°È¡A¸Ó¦X¬ù¹ï©ó¥¼¨ÓÀ禬°^Äm¡A¨Ì¤½¶}¸ê°TÆ[´ú¯¸¨C¤ëÀ禬¤§¤½§i°T®§¤Î·| p®v¬d®Ö©Î®Ö¾\¤§¦U´Á°]°È³ø§i¤½§i°T®§¬°¥D¡C 7.¹ï¤½¥q°]°È¡B·~°È¤§¼vÅT(¸Ñ°£ªÌ¤£¾A¥Î):¥»¤½¥q±NÀò±oñ¬ùª÷200¸U¬üª÷(ùÚÁl¥Íª«Âå ÃÄ©óñ¬ù«á45¤Ñ¤º¤ä¥I)¤Î³Ì°ª¹F2,400¸U¬üª÷¤§¨½µ{¸Oª÷¥H¤Î¨Ì¾P°â²bÃB¤À¼h¦¬¨ú¤§Åv §Qª÷¡A¨Ã¬ù©w¥Ñ¥»¤½¥q¨ó§U²ÎÄw«ö·Ó°ê»Ú¦h¤¤¤ß¤è¦¡¶}®i¥»¶µ¥Ø²ÄII´Á©M²ÄIII´Á¤§Á{ §É¬ã¨s¡AùÚÁl¥Íª«ÂåÃÄt³d¹ê¬I©MºÞ²z¨È¬w°ÏªºÁ{§É¬ã¨s¤u§@¡At¾á¥»¶µ¥Ø¦b¨È¬w°Ïªº Á{§É¬ã¨s¶O¥Î»PÃÄ«~µù¥U¬ÛÃö¶O¥Î¡A¨Ã©óÀò±o§åã¤W¥««á¡At³d¸Ó¶µ¥Ø¦b¨È¬w°Ïªº°Ó·~ ¤Æ±À¼s¡C 8.¨ãÅé¥Øªº(¸Ñ°£ªÌ¤£¾A¥Î):¨ó§U¥»¤½¥q¶}µo«D°sºë©Ê¯×ªÕ¨xª¢(NASH)ÂåÀø¥«³õ¤Î¨ä¥L¾A À³¯g¤§ªk³W®Öã¤Î°Ó«~¤Æ¬¡°Ê¡C 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ: (1) ùÚÁl¥Íª«ÂåÃĬO¤@®a¥Íª«»sÃĤ½¥q¡A±Mª`©ó¶}µo¤Î°Ó·~¤Æ³Ð·s¦Û¥D§K¬Ì¡B®ø¤Æ¹D©M ¤¤¼Ï¯«¸g¨t²Î¯e¯fªvÀøªºÃĪ«¡A¥Hº¡¨¬¤¤°ê©M¥þ²y¬ÛÃö¯e¯fªvÀøªº¢¤Á»Ý¨D¡CùÚÁl¥Íª« ÂåÃĦb³Ð·sÃÄÁ{§É«e¬ã¨s©MÁ{§É¶}µo¤è±¾Ö¦³Â×´I¸gÅ窺¥@¬É¯Å¬ãµo¹Î¶¤¡A¨Ã±Mª`©ó³Ð ·sÃĪºÁ{§É¶}µo¡C (2)ùÚÁl¥Íª«ÂåÃĬ°ªC¦{®õ®æÂåÃĬì§ÞªÑ¥÷¦³¤½¥q(²`¦`ÃÒ¨é¥æ©ö©Ò¡G300347.SZ)¤§Âà §ë¸ê¤½¥q¡AªC¦{®õ®æÂåÃĬ°°ê¤º¥~ÂåÃĤÎÂåÀø¾¹±ñ²£«~ªº¬ã¨s¶}µo´£¨Ñ±M·~Á{§É¬ã¨sªA °È,·~°È½d³ò¥Dn¥]¬AI¦ÜIV´ÁÁ{§É¸ÕÅç§Þ³NªA°È¡B¸ê®ÆºÞ²z¤Î²Îp¤ÀªR¡Bµù¥U¥Ó³ø¡BÁ{ §É¸ÕÅç±wªÌ©Û¶Ò¡BSMOªA°È¡BÂå¾ÇÀË´úªA°È¡BÂå¾Ç¸ê®Æ½Ķ¡BÂå¾Ç¼v¹³¶EÂ_ªA°È©M°ö°VªA °È¡CªC¦{®õ®æÂåÃĶ°¹Î2018¦~1-9¤ëÀç·~¦¬¤J¬ù15.94»õ¤H¥Á¹ô¡A2018¦~¥þ¦~²b¬Õ§Q¶W¹L 4.5»õ¤H¥Á¹ô¡C
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/28 | ¥Ý¦ù°ó¥Í§Þ ¿³ | ¥»¤½¥q°w¹ïª¢©Ê¸z¹D¯e¯f©Ò¶}µo¤§·s¾¯«¬/·s½Æ¤èÃĪ«IBD98-M¡A¨ä²Ä |
¥»¤½¥q°w¹ïª¢©Ê¸z¹D¯e¯f©Ò¶}µo¤§·s¾¯«¬/·s½Æ¤èÃĪ«IBD98-M¡A¨ä²Ä¢ºa´Á¤HÅéÁ{§É¸ÕÅçµû¦ô«ü¼Ð¤§²Îpµ²ªG
1.¨Æ¹êµo¥Í¤é:108/02/27 2.¤½¥q¦WºÙ:¥Ý¦ù°ó¥Í§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò(Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¥»¤½¥q¥HMesalamineÃĪ«¤Î³z©ú½è»Ä(Sodium Hyaluronate)§@¬°¦³®Ä¦¨¥÷(Active Ingredients)¡A§Q¥Î¦h¼h·L²É¥]ÂЧ޳N(multi-layer coating pellet technology, MLCP)»s³y¡A°w¹ïª¢©Ê¸z¹D¯e¯f(Inflammatory Bowel Diseases, IBD)©Ò¶}µo¤§ ·s¾¯«¬/·s½Æ¤èÃĪ«IBD98-M¡A¨ä²Ä¢ºa´Á¤HÅéÁ{§É¸ÕÅçµû¦ô«ü¼Ð¤§²Îpµ²ªG¡C 6.¦]À³±¹¬I:µL 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ¤@¡B¬ãµo·sÃĦWºÙ©Î¥N¸¹¡GIBD98-M¡C ¤G¡B¥Î³~¡G¥Î©óªvÀøª¢©Ê¸z¹D¯e¯f¤§®ò°ò¤ô·¨»ÄÆQÃþÃĪ«¡C ¤T¡B¹wp¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G²Ä¢ºb´Á¡B²Ä¢»´Á¤HÅéÁ{§É¸ÕÅç¤Î·sÃĬdÅçµn°O¡C ¥|¡B¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G (¤@)´£¥X¥Ó½Ð¡þ³q¹L®Öã¡þ¤£³q¹L®Öã¡þ¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¡G 1.Á{§É¸ÕÅ礶²Ð¡G (1)¸ÕÅçp¹º¦WºÙ¡G¥HIBD98-M½wÄÀ½¦Ån(delayed-release capsules)ªvÀø »´«×¦Ü¤¤«×¼ìºÅ©Êµ²¸zª¢±wªÌ(active, mild to moderate Ulcerative Colitis)¡A±Ä¦h¤¤¤ß¡BÀH¾÷¡BÂùª¼¡B¥¦æ¤Î¦w¼¢¾¯¹ï·Ó¤§²Ä¢ºa´Á¤HÅé Á{§É¸ÕÅç¡C (2)¸ÕÅç¥Øªº¡G¥Dnµû¦ô¥H¤£¦P¾¯¶q¤§IBD98-MªvÀøµ²¸zª¢±wªÌ¡A»P¦w¼¢ ¾¯²Õ¤ñ¸û¤§Àø®Ä¡C (3)¸ÕÅ綥¬q¤À¯Å¡G²Ä¢ºa´Á¤HÅéÁ{§É¸ÕÅç¡C (4)¸ÕÅçÃĪ«¡G0.8§J/¤é IBD98-M¡B1.2§J/¤é IBD98-M¡A³sÄòªA¥Î¤»¶g (Duration of Treatment)¡C (5)«ÅºÙ¾AÀ³¯g¡G»´«×¦Ü¤¤«×¼ìºÅ©Êµ²¸zª¢±wªÌ¡C (6)¸ÕÅçp¹º¨ü¸ÕªÌ¦¬¯Ç¤H¼Æ¡G51¤H¡C 2.µû¦ô«ü¼Ð»¡©ú¡G (1)¥DnÀø®Ä«ü¼Ð¡G©ó6¶g¤fªAIBD98-M«á¡A»P¦w¼¢¾¯²Õ(Placebo)¹ï·Ó¡A ¤ñ¸û¦U²Õ¯f¤H½w¸Ñ(remission)ªº¤ñ²v¡F½w¸Ñªº©w¸q«Y¨Ì¡u§ï¨}«¬¼ìºÅ ©Êµ²¸zª¢¬¡©Ê«ü¼Æ(Modified Ulcerative Colitis Disease Activity Index; modified UCDAI)¡v§@µû¦ô¡A·ímodified UCDAI¡Ø1¡A¥Bª½¸z ¥X¦å¡B±Æ«K¦¸¼Æ¤ÎµLÂH½¤©ö¯Ü©Ê(no mucosal friability)ªº¤À¼Æ¬°0¡B ¥H¤Î¤Aª¬µ²¸zÃèÀˤÀ¼Æ¤£¶W¹L1®É¡A§Y¹F¨ì½w¸Ñ¡C (2)¦¸nÀø®Ä«ü¼Ð¡G A.©óªvÀø6¶g«á¡A»P°_ÂI´ú¶qÈ(baseline)¤ñ¸ûÁ{§É§ïµ½¤ñ²v(clinical improvement rate)¡B¤ºµøÃèÀ˧ﵽ»P¯gª¬ÅܤƵ¥¡C B.µû¦ô¦w¥þ©Ê(safety)¤Î@¨ü©Ê(tolerability profile)¡GªvÀø¬ÛÃö ¤£¨}¨Æ¥ó(TEAEs)ªºµo¥Í²v(incidence)¤ÎÄY«µ{«×(severity)¡A¥H¤Î ÄY«¤£¨}¤ÏÀ³¨Æ¥ó¡]Serious Adverse Event, SAE¡^ªºµo¥Í²v¤Î ÄY«µ{«×¡C 3.¸ÕÅçµ²ªG¤ÀªR»P·N¸q (1)¥DnÀø®Ä«ü¼Ð¡G0.8§J/¤é¸ÕÅçÃĪ«²Õ©Î1.2§J/¤é¸ÕÅçÃĪ«²Õ¡A»P¦w¼¢ ¾¯²Õ¤ñ¸û¡A©ó²Îp¤WµLÅãµÛ®t²§¡C (2)¦¸nÀø®Ä«ü¼Ð¡G A.0.8§J/¤é¸ÕÅçÃĪ«²Õ©Î1.2§J/¤é¸ÕÅçÃĪ«²Õ¡AÁ{§É§ïµ½¤ñ²v(clinical improvement rate)¡B¤ºµøÃèÀ˧ﵽ»P¯gª¬ÅܤƵ¥»P¦w¼¢¾¯²Õ¤ñ¸û¡A ©ó²Îp¤WµLÅãµÛ®t²§¡C B.¦w¥þ©Ê¤Î@¨ü©Ê¡G¦b¦¹¸ÕÅ礤¡AµLÄY«ªºªvÀø¬ÛÃö¤£¨}¨Æ¥ó(TEAEs) ³Q³ø§i¡A¥BµLÄY«¤£¨}¤ÏÀ³¨Æ¥ó(SAE)³Q³ø§i¡C (3)¨ä¥¦¡G A.©óªvÀø´Á¶¡(6¶g)µ²§ô®ÉÆ[¹îmodified UCDAI¤À¼Æ¡A1.2§J/¤é¸ÕÅçÃÄ ª«²Õ(¤U°´T«×¬°1.64)»P0.8§J/¤é¸ÕÅçÃĪ«²Õ(¤U°´T«×¬°0.83)¡B ¦w¼¢¾¯²Õ(¤U°´T«×¬°0.64)¤ñ¸û¡A¦³¸û°ªªº¤À¼Æ¤U°¡C B.©ómodified UCDAI¤À¼Æ²Õ¦¨¤¤¡A¤£p¤J¤ºµøÃèÀ˧ﵽ¤À¼Æ¡A1.2§J/¤é ¸ÕÅçÃĪ«²Õ(¤U°´T«×¬°1.85)»P0.8§J/¤é¸ÕÅçÃĪ«²Õ(¤U°´T«×¬° 0.36)¡B¦w¼¢¾¯²Õ(¤U°´T«×¬°1.25)¤ñ¸û¡A¦³¸û°ªªº¤À¼Æ¤U°¡C C.©ó¯f¤H¦Û¥D³ø§i¤À¼Æ²Õ¦¨¤¤¡A¤£p¤J¤ºµøÃè´î¤ÎÂå¥Íµû¦ô¶µ¥Ø¤§§ïµ½ ¤À¼Æ¡A1.2§J/¤é¸ÕÅçÃĪ«²Õ(¤U°´T«×¬°1.25)»P0.8§J/¤é¸ÕÅçÃĪ«²Õ (¤U°´T«×¬°0.15)¡B¦w¼¢¾¯²Õ(¤W¤É0.14)¤ñ¸û¡A¦³¸û°ªªº¤À¼Æ¤U°¡C D.¥»¤½¥q¥t¥H¼s¸q¦ôp¤èµ{¦¡¡]Generalized Estimating Equation, GEE¡^²Îp¤èªkpºâ¡G1.2§J/¤é¸ÕÅçÃĪ«²Õ¡A©ómodified UCDAIÁ`¤À (p=0.0132)¡Bª½¸z¥X¦åµû¤À(Rectal Bleeding Score)(p=0.0037)¡B ±Æ«K¦¸¼Æµû¤À(Stool Frequency Score)(p=0.0070)¡BªvÀøÂå®vµû¤À (Physician Assessment Score)(p=0.0013)µ¥¡A¨ä²Õ¤ºÅܲ§ (Within-Group Variation)(V6 vs. V3)©ó²Îp¤W¦³ÅãµÛ®t²§¡C 4.³æ¤@Á{§É¸ÕÅçµ²ªG(¥]§t¥D¡B¦¸nµû¦ô«ü¼Ð¤§²Îp¾ÇPȤβÎp¾Ç¤W¬O§_¹F ÅãµÛ·N¸q)¡A¨Ã¤£¨¬¥H¥R¤À¤Ï¬M¥¼¨Ó·sÃĶ}µo¤W¥«¤§¦¨±Ñ¡A§ë¸ê¤HÀ³¼f·V§PÂ_ ÂÔ·V§ë¸ê¡C (¤@)´£¥X¥Ó½Ð¡þ³q¹L®Öã¡þ¤£³q¹L®Öã¡þ¦U´Á¤HÅéÁ{§É¸ÕÅç(§t´Á¤¤¤ÀªR)µ²ªG¡G (¤G)¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡A¤½¥q©Ò±Á{¤§·ÀI¤Î¦]À³±¹¬I¡G¤£¾A¥Î (¤T)¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥i¡A¥¼¨Ó¸gÀç¤è¦V¡G¤£¾A¥Î¡C (¥|)¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G«YÄÝ¥¼¨Ó±ÂÅv½Í§P¤§¸ê°T¡A¬°§K¼vÅT±ÂÅvª÷ÃB¡A¼È¤£ ´¦ÅS¥H«O»Ù¤½¥q¤Î§ë¸ê¤HÅv¯q¡C ¤¡B±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G (¤@)¹wp§¹¦¨®É¶¡¡G¥»¤½¥q¹wp©ó2019¦~²Ä¤G©u»PUS FDA°Q½×¥»®×¡A¨Ã¿n·¥´M§ä ¦X§@¹ï¶H¡A¥H±ÂÅv¦X§@¤è¦¡¶i¦æIBD98-M«áÄò¤§Á{§É¸ÕÅç¡A±N¨Ì«ez¨Æ¶µ¤§ °õ¦æ±¡§Î¡A³W¹º¤U¤@¶¥¬q¤§Á{§É¹êÅç (¤G)¹wpÀ³t¾á¤§¸q°È¡GIBD98-M¬°¥»¤½¥q¦Û¥D¶}µo¤§·s¾¯«¬ÃĪ«¡A¨Ã¤w«Ø¥ß¬ÛÃö ±M§Q§G§½¡A¬G¥»¶µ¤£¾A¥Î¡C ¤»¡B¥«³õ²{ªp¡G5-aminosalicylic acid (5-ASA)ÃĪ«¦bªvÀøª¢©Ê¸z¹D¯e¯fªºÃĪ«É]³õ ¤¤¡A¬°Step Up§ëÃĪvÀøµ¦²¤¤¤ªº²Ä¤@½u¥ÎÃÄ¡F®Ú¾ÚVisiongainªº¹w¦ô¡A ©ó2018~2020¦~¦¹ÃþÃĪ«ªºÉ]³õ³W¼Ò¬ù¬°17.6~18.4»õ¬ü¤¸¡C ¤C¡B·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/28 | ©_Üg¬ì§Þ | ¤½§i108¦~01¤ë¥÷¦Ûµ²°]°È³ø§i¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¤Î³t°Ê¤ñ²v |
1.¨Æ¹êµo¥Í¤é:108/02/27 2.¤½¥q¦WºÙ:©_Üg¬ì§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò(Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î 5.µo¥Í½t¥Ñ:¦]¥»¤½¥q104¦~«×²ÄQ2©u°]°È³ø§i¤§t¶Å¤ñ²v¹F67.6%¡A ¨ÌÂd¶R¤¤¤ßÃÒÂd¼f¦r²Ä1040101534¸¹¨çn¨D¿ì²z¤½§i 6.¦]À³±¹¬I: ¨C¤ë©³«e¤½§i¦Ûµ²°]°È³ø§iºI¦Ü«e¤@¤ë©³¤§t¶Å¤ñ²v¡B¬y°Ê¤ñ²v¤Î³t°Ê¤ñ²v¡C 108¦~01¤ë¥÷¦Ûµ²°]°È³ø§i¤§°]°È¤ñ²v t¶Å¤ñ²v=56.27% ¬y°Ê¤ñ²v=171.84% ³t°Ê¤ñ²v=79.07% 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ³ÕÁ¾¥Í§Þ ¥¼ | ¼á²M´CÅé108¦~03¤ë04¤é¸gÀÙ¤é³ø²ÄC06ª©´Á³f³¡¥÷³ø¾É·s»D¤º®e |
1.¶Ç¼½´CÅé¦WºÙ:¸gÀÙ¤é³ø²ÄC06ª©´Á³f 2.³ø¾É¤é´Á:108/03/04 3.³ø¾É¤º®e: ¡u³ÕÁ¾±N³°Äò¦³¦h´ÚÃĪ«¶i¤J¶q²£¡A¨ä¤¤¯E¹©©e°U³ÕÁ¾¥Í§Þ»s³y¦×¬r±ìµß¯À·sÃÄ OBI-858Á{§É¸ÕÅçÃÄ«~¡A¹wp¤W¥b¦~¶}©lÁ{§É¥ÎÃĪ«¥Í²£¡C...©e°U»s³y¤§¥Íª« ¬Û¦ü©Ê·sÃÄ°w¾¯¡A¹wp±N©ó©ú¦~¥Ó½Ð¼Ú¬wÃÄÃÒ¤W¥«¡C¡v 4.§ë¸ê¤H´£¨Ñ°T®§·§n:¤£¾A¥Î 5.¤½¥q¹ï¸Óµ¥³ø¾É©Î´£¨Ñ°T®§¤§»¡©ú: ¦³Ãö¥»¤½¥q¹ê»Ú¤§°]°È¤Î·~°È¸ê°T±x¥H¤½¶}¸ê°TÆ[´ú¯¸¤½§G¤§¸ê®Æ¬°·Ç¡A¦³Ãö ´CÅé³ø¾É¡A·q½Ð§ë¸ê¤H¼f·V§PÂ_¡A¥H«O»Ù¦Û¨Åv¯q¡C 6.¦]À³±¹¬I:³z¹L¤½¶}¸ê°TÆ[´ú¯¸µo¥¬«¤j°T®§»¡©ú¡A½T«O§ë¸ê¤HÅv¯q¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¤T«a¤ý¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H³\¯¾»í 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¤T«a¤ý¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:ªL¹©³Ó (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;71,694,883ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ;71,694,883ªÑ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;71,694,883ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:60% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ´ä³£¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H¶À«Ø¥þ 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ´ä³£¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;79,898,064ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;79,898,064ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:40% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ÄR«a¦³½u ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H¬ö¤Dºû 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ÄR«a¦³½u ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;125,788,333ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;125,788,333ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:40% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¸U¶H¦³½u ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H¬ö¤Dºû 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¸U¶H¦³½u ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:±i®Ñ»Ê (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;95,238,998ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;95,238,998ªÑ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ;95,238,998ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:60% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¼yÁp¦³½u¹qµø ¤½ | ¤½§iÁ`¸g²z²§°Ê |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):Á`¸g²z 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¶À¬K»¨ 4.·s¥ôªÌ©m¦W¤Î²¾ú:¶À«Ø¥þ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¼yÁp¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H¶À«Ø¥þ 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ¼yÁp¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;96,058,355ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;96,058,355ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:40% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ®a©M¦³½u¹qµø ¤½ | §ó¥¿¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:ªL¹©³Ó (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ;171,458,147ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;171,458,147ªÑ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;171,458,147ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:60% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ®a©M¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥qªk¤H¸³¨Æ§ï¬£¥Nªí¤H |
1.µo¥ÍÅܰʤé´Á:108/02/27 2.ÂÂ¥ôªÌ©m¦W¤Î²¾ú: ¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:ªL¹©³Ó (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¯ÊÃB (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:§Å«T¼Ý 3.·s¥ôªÌ©m¦W¤Î²¾ú: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À°·¥þ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý 4.²§°Êì¦]:§ï¬£ 5.·s¥ô¸³¨Æ¿ï¥ô®É«ùªÑ¼Æ: ·s¥ô¸³¨Æ (1)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¶À«Ø¥þ;171,458,147ªÑ (2)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:´¦´ÂµØ;171,458,147ªÑ (3)¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H:¾G·s¥Ý;171,458,147ªÑ 6.ì¥ô´Á¡]¨Òxx/xx/xx¦Üxx/xx/xx¡^:107/10/25~110/10/24 7.·s¥ô¥Í®Ä¤é´Á:108/02/27~110/10/24 8.¦P¥ô´Á¸³¨ÆÅܰʤñ²v:60% 9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
2019/2/27 | ·sµøªi¦³½u¹qµø ¤½ | ¤½§i¥»¤½¥q¸³¨Æ·|§ï¿ï¸³¨Æªø |
1.¸³¨Æ·|¨Mij¤é:108/02/27 2.ÅܰʤHû¾ºÙ(½Ð¿é¤J¡©¸³¨Æªø¡ª©Î¡©Á`¸g²z¡ª):¸³¨Æªø 3.ÂÂ¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H³¯·ØÄP 4.·s¥ôªÌ©m¦W¤Î²¾ú:¤¤¹Åºô¸ôªÑ¥÷¦³¤½¥q¥Nªí¤H´¦´ÂµØ 5.²§°Êì¦]:¸g¸³¨Æ·|¨Mij³q¹L 6.·s¥ô¥Í®Ä¤é´Á:108/02/27 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL
<ºK¿ý¤½¶}¸ê°TÆ[´ú¯¸-¡·¥²´Iºô¡·¤p½s¾ã²z¡B¦P½èºô¯¸¥¼¸g±ÂÅv½Ð¤Åª½±µ½Æ»s>
|
|
|